Form 8-K Karyopharm Therapeutics For: Nov 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Karyopharm Therapeutics (KPTI) Tops Q3 EPS by 2c
November 9, 2015 9:22 AM ESTKaryopharm Therapeutics (NASDAQ: KPTI) reported Q3 EPS of ($0.85), $0.02 better than the analyst estimate of ($0.87).
For earnings history and earnings-related data on Karyopharm Therapeutics (KPTI) click here.
... More


